James Doyle, CRNA | |
321 Mitchell Ave, Batesville, IN 47006-8909 | |
(800) 277-8151 | |
Not Available |
Full Name | James Doyle |
---|---|
Gender | Male |
Speciality | Nurse Anesthetist, Certified Registered |
Location | 321 Mitchell Ave, Batesville, Indiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558464347 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 28104766A (Indiana) | Primary |
Entity Name | Premier Anesthesia Associates, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043276553 PECOS PAC ID: 2062498140 Enrollment ID: O20041026000155 |
News Archive
Have you ever accidently missed a red light or a stop sign? Or have you heard someone mention a visible event that you passed by but totally missed seeing?
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead product candidate, APF530, for the prevention of acute- and delayed-onset chemotherapy-induced nausea and vomiting (CINV).
Watson Pharmaceuticals, Inc., today confirmed that the United States District Court for the District of Massachusetts has granted Momenta Pharmaceuticals, Inc. and Sandoz Inc.'s request for a preliminary injunction preventing Watson and Amphastar Pharmaceuticals, Inc. from marketing or selling Amphastar's Enoxaparin Sodium Injection, a generic equivalent to Sanofi-aventis' LOVENOX.
WebMD Health Corp. announced today the preliminary results of its tender offer to purchase up to 5,800,000 shares of its common stock at a price of $46.80 per share, which expired at 5:00 p.m., New York City time on April 8, 2010.
A new analysis indicates that the use of opioid pain medications in older US rheumatoid arthritis patients peaked in 2010 and is now declining slightly. By 2014, 41% of rheumatoid arthritis patients were regular opioid users.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
James Doyle, CRNA 22195 Pocket Rd, Batesville, IN 47006-7494 Ph: (812) 934-4099 | James Doyle, CRNA 321 Mitchell Ave, Batesville, IN 47006-8909 Ph: (800) 277-8151 |
News Archive
Have you ever accidently missed a red light or a stop sign? Or have you heard someone mention a visible event that you passed by but totally missed seeing?
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead product candidate, APF530, for the prevention of acute- and delayed-onset chemotherapy-induced nausea and vomiting (CINV).
Watson Pharmaceuticals, Inc., today confirmed that the United States District Court for the District of Massachusetts has granted Momenta Pharmaceuticals, Inc. and Sandoz Inc.'s request for a preliminary injunction preventing Watson and Amphastar Pharmaceuticals, Inc. from marketing or selling Amphastar's Enoxaparin Sodium Injection, a generic equivalent to Sanofi-aventis' LOVENOX.
WebMD Health Corp. announced today the preliminary results of its tender offer to purchase up to 5,800,000 shares of its common stock at a price of $46.80 per share, which expired at 5:00 p.m., New York City time on April 8, 2010.
A new analysis indicates that the use of opioid pain medications in older US rheumatoid arthritis patients peaked in 2010 and is now declining slightly. By 2014, 41% of rheumatoid arthritis patients were regular opioid users.
› Verified 2 days ago
Robert L Hurm, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 321 Mitchell Ave, Batesville, IN 47006 Phone: 812-933-5120 | |
Barbara Wenning, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 321 Mitchell Ave, Batesville, IN 47006 Phone: 812-934-6624 Fax: 765-284-2434 |